Genetic interaction of P2X(7) receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients

Por Solini, Anna, Simeon, Vittorio, Derosa, Lisa, Orlandi, Paola, Rossi, Chiara, Fontana, Andrea, Galli, Luca, Di Desidero, Teresa, Fioravanti, Anna, Lucchesi, Sara, Coltelli, Luigi, Ginocchi, Laura, Allegrini, Giacomo, Danesi, Romano, Falcone, Alfredo, Bocci, Guido
Publicado no Oncotarget (2015)

Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers

Por Allegrini, Giacomo, Di Desidero, Teresa, Barletta, Maria Teresa, Fioravanti, Anna, Orlandi, Paola, Canu, Bastianina, Chericoni, Silvio, Loupakis, Fotios, Di Paolo, Antonello, Masi, Gianluca, Fontana, Andrea, Lucchesi, Sara, Arrighi, Giada, Giusiani, Mario, Ciarlo, Andrea, Brandi, Giovanni, Danesi, Romano, Kerbel, Robert S., Falcone, Alfredo, Bocci, Guido
Publicado em 2012

Prospective Validation of Candidate SNPs of VEGF/VEGFR Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Plus Bevacizumab

Por Loupakis, Fotios, Cremolini, Chiara, Yang, Dongyun, Salvatore, Lisa, Zhang, Wu, Wakatsuki, Takeru, Bohanes, Pierre, Schirripa, Marta, Benhaim, Leonor, Lonardi, Sara, Antoniotti, Carlotta, Aprile, Giuseppe, Graziano, Francesco, Ruzzo, Annamaria, Lucchesi, Sara, Ronzoni, Monica, De Vita, Ferdinando, Tonini, Giuseppe, Falcone, Alfredo, Lenz, Heinz-Josef
Publicado em 2013